The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina

Experimental Eye Research

Volumn 87, Issue 1, 2008, Pages 22-29

  Lüke, Matthias ^a   Januschowski, Kai ^a   Beutel, Julia ^a   Warga, Max ^a   Grisanti, Salvatore ^c   Peters, Swaantje ^a   Schneider, Toni ^b   Lüke, Christoph ^b   Bartz Schmidt, Karl Ulrich ^a   Szurman, Peter ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

electroretinogram; isolated perfused retina; retinal toxicity; triamcinolone

Indexed keywords

TRIAMCINOLONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; COW; CYTOTOXICITY; ELECTRORETINOGRAM; EYE TOXICITY; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CATTLE; ELECTRORETINOGRAPHY; MODELS, BIOLOGICAL; RETINA; RETINAL GANGLION CELLS; TRIAMCINOLONE ACETONIDE;

EID: 45949131697     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.04.005     Document Type: Article

References (24)

1. Beer P.M., Bakri S.J., Singh R.J., Liu W., Peters III G.B., and Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 (2003) 681-686
2. Chen S.D., Sundaram V., Lochhead J., and Patel C.K. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am. J. Ophthalmol 141 (2006) 876-883
3. Chin H.S., Park T.S., Moon Y.S., and Oh J.H. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 25 (2005) 556-560
4. Hanawa I., and Tateishi T. The effect of aspartate on the electroretinogram of the vertebrate retina. Experientia 26 (1970) 1311-1312
5. Hernaez-Ortega M.C., and Soto-Pedre E. A simple and rapid method for purification of TA acetonide suspension for intravitreal injection. Ophthalmic Surg. Lasers Imag 35 (2004) 350-351
6. Jaissle G.B., Szurman P., and Bartz-Schmidt K.U. Ocular side effects and complications of intravitreal TA acetonide injection. Ophthalmologe 101 (2004) 121-128
7. Jonas J.B., and Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am. J. Ophthalmol 132 (2001) 425-427
8. Jonas J.B., Kreissig I., Söfker A., and Degenring R.F. Intravitreal injection of TA for diffuse diabetic macular edema. Arch. Ophthalmol 121 (2003) 57-61
9. Kim H., Csaky K.G., Gravlin L., Yuan P., Lutz R.J., Bungay P.M., Tansey G., DE Monasterio F., Potti G.K., Grimes G., and Robinson M.R. Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina 26 (2006) 523-530
10. Lang Y., Zemel E., Miller B., and Perlman I. Retinal toxicity of intravitreal kenalog in albino rabbits. Retina 27 (2007) 778-788
11. Lüke C., Walter P., Bartz-Schmidt K.U., and Sickel W. Effects of antiviral agents on retinal function in vertebrate retina. In: Green K. (Ed). Advances in Ocular Toxicology (1997), Plenum Press, New York 107-112
12. Lüke M., Weiergräber M., Brand C., Siapich S.A., Banat M., Hescheler J., Lüke C., and Schneider T. The isolated perfused bovine retina-a sensitive tool for pharmacological research on retinal function. Brain Res. Brain Res. Protoc 16 (2005) 27-36
13. Macky T.A., Helmy D., and El Shazly N. Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study. Graefes Arch. Clin. Exp Ophthalmol 245 (2007) 817-824
14. Martidis A., Duker J.S., Greenberg P.B., Rogers A.H., Puliafito C.A., Reichel E., and Baumal C. Intravitreal TA for refractory diabetic macular degeneration. Ophthalmology 109 (2002) 920-927
15. Narayanan R., Mungcal J.K., Kenney M.C., Seigel G.M., and Kuppermann B.D. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest. Ophthalmol. Vis. Sci 47 (2006) 722-728
16. Schindler R.H., Chandler D., Thresher R., and Machemer R. The clearance of intravitreal TA acetonide. Am. J. Ophthalmol 93 (1982) 415-417
17. Shaikh S., Ho S., Engelmann L.A., and Klemann S.W. Cell viability effects of TA acetonide and preservative vehicle formulations. Br. J. Ophthalmol 90 (2006) 233-236
18. Sickel W. Respiratory and electrical responses to light stimulation in the retina of the frog. Science 148 (1965) 648-651
19. Szurman P., Kaczmarek R., Spitzer M.S., Jaissle G.B., Decker P., Grisanti S., Henke-Fahle S., Aisenbrey S., and Bartz-Schmidt K.U. Differential toxic effect of dissolved TA and its crystalline crystals on cultured human retinal pigment epithelium (ARPE19) cells. Exp. Eye Res 83 (2006) 584-592
20. Szurman P., Sierra A., Kaczmarek R., Jaissle G.B., Wallenfels-Thilo B., Grisanti S., Lüke M., Bartz-Schmidt K.U., and Spitzer M.S. Different biocompatibility of crystalline TA crystals on retinal cells in vitro and in vivo. Exp. Eye Res 85 (2007) 44-53
21. Valamanesh F., Torriglia A., Savoldelli M., Gandolphe C., Jeanny J.C., BenEzra D., and Behar-Cohen F. Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Mol. Vis 13 (2007) 1746-1757
22. Walter P., Lüke C., and Sickel W. Antibiotics and light responses in superfused bovine retina. Cell. Mol. Neurobiol 19 (1999) 87-92
23. Yeung C.K., Chan K.P., Chiang S.W.Y., Pang C.P., and Lam D.S.C. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of TA. Invest. Ophthalmol. Vis. Sci 44 (2003) 5293-5300
24. Yu S.Y., Damico F.M., Viola F., D'Amico D.J., and Young L.H. Retinal toxicity of intravitreal TA acetonide: a morphological study. Retina 26 (2006) 531-536